MedTrace Logo

Gaze Contingent Feedback in Major Depressive Disorder (MDD)

NCT02945735 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-12-18

No results posted yet for this study

Summary

The purpose of this study is to determine whether giving gaze-contingent feedback is an effective attention modification procedure, helping in the treatment of Major Depressive Disorder (MDD)

Conditions

  • Depression, Unipolar
  • Depressive Disorder
  • Depressive Disorder, Major

Interventions

BEHAVIORAL

Attention Modification

Feedback according to participants' viewing patterns, in order to modify their attention.

Sponsors & Collaborators

  • Tel Aviv University

    lead OTHER

Principal Investigators

  • Yair Bar-Haim, Phd · Tel Aviv University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-06
Primary Completion
2019-01-07
Completion
2019-01-07

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02945735 on ClinicalTrials.gov